RxDoctor Payments Data

Gregory Floyd, MD

Family Medicine · Carrollton, GANPI 1326066895

Payments from drug & device makers

$8,805in general payments, 2019–2025

Across 511 payments — averaging $17.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$957
  • Astellas Pharma US Inc$688
  • Pfizer$647
  • Esperion Therapeutics, Inc.$586
  • GSK$572
  • plus $4K from 38 others

What the payments were for

  • Food & beverage$8,69299%
  • Education$991%
  • Entertainment$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,805 in reported general payments places this provider in the 90th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$73,651
Medicare patients
222
Services billed
6,482

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RybelsusSemaglutide95$160,866
Trelegy ElliptaFluticasone/Umeclidin/Vilanter102$96,266
OzempicSemaglutide78$94,509
TrulicityDulaglutide67$76,126
JardianceEmpagliflozin46$69,276
EliquisApixaban92$68,549
MounjaroTirzepatide49$51,121
LinzessLinaclotide68$46,285
JanuviaSitagliptin Phosphate36$45,193
FarxigaDapagliflozin Propanediol27$30,975
MyrbetriqMirabegron47$25,134
XareltoRivaroxaban11$13,466
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen561$13,310
Combivent RespimatIpratropium/Albuterol Sulfate15$8,741
NexletolBempedoic Acid15$8,514

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus, Ozempic$957$255,374173 claims
Lilly USA, LLCTrulicity, Mounjaro$451$127,247116 claims
GSKTrelegy Ellipta$572$96,266102 claims
Boehringer IngelheimJardiance, Combivent Respimat, Tradjenta$213$84,41174 claims
PfizerEliquis$647$68,54992 claims
MerckJanuvia, Belsomra$33$52,37951 claims
AbbVieLinzess$1,340$46,28568 claims
AstraZenecaFarxiga, Symbicort$539$33,41138 claims
Astellas Pharma US IncMyrbetriq$688$25,13447 claims
Johnson & JohnsonXarelto$299$13,46611 claims
Esperion Therapeutics, Inc.Nexletol$586$8,51415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Carrollton

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →